Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05092516 · ClinicalTrials.gov registry record · NA
Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
A NA study of Post Acute Sequelae of COVID-19 and Dysexecutive Syndrome, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05092516: Active NA study of Post Acute Sequelae of COVID-19 and Dysexecutive Syndrome, sponsored by Massachusetts General Hospital.
NCT05092516 is a NA study of Post Acute Sequelae of COVID-19 and Dysexecutive Syndrome that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 182-participant average among 8 other Post Acute Sequelae of COVID-19 trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05092516, a NA study of Post Acute Sequelae of COVID-19 and Dysexecutive Syndrome, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric currents delivered to the brain through stimulation electrodes on the scalp.
Primary Outcome
Performance during the incongruent trials of the Eriksen Flanker Task were assessed at baseline (before the beginning of the 4-week home tDCS intervention). The performance is quantified as the ratio of correct responses to all responses. For example, a score of 0.70 indicates that the participant responded to 70% of the trials correctly.
Conditions Studied
Interventions
- DEVICE Sham tDCS
- DEVICE Active tDCS
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-06-07 |
| Est. Completion | 2026-06-15 |
| Phase | NA |
What the registry record for NCT05092516 still lists
NCT05092516 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 182-participant average among 8 other Post Acute Sequelae of COVID-19 trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Post Acute Sequelae of COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Sham tDCS is the first listed.
NCT05092516 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05092516 about?
NCT05092516 is a clinical study titled "Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)". The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric current...
What is the current status of trial NCT05092516?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-06-07. Estimated completion is 2026-06-15.
What conditions does trial NCT05092516 study?
This clinical trial studies the following conditions: Post Acute Sequelae of COVID-19, Dysexecutive Syndrome.
What interventions are being tested in trial NCT05092516?
The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE).
Who is sponsoring clinical trial NCT05092516?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05092516 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Acute Sequelae of COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05092516's enrollment target sits among peer trials
40 6th of 8 higher than 2 of 8 other Post Acute Sequelae of COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Acute Sequelae of COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autoimmune Intervention Mastery Course Study
RECRUITING · NA
-
Mind Body Intervention for Long COVID-19
RECRUITING · NA
-
Diaphragmatic Breathing Exercises for Post-COVID-19 Diaphragmatic Dysfunction (DD)
COMPLETED · NA
-
COVID-19 Outcome Prediction Algorithm
RECRUITING
-
AT1001 for the Treatment of Long COVID
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI